CytomX Therapeutics, Inc. (CTMX): Shares Outstanding
170.19M
As of 2025-12-31
+37.0%
3-year compound annual growth
+28.7%
5-year compound annual growth
+16.8%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 170.19M | +112.5% | 2026-03-16, Balance as of period end |
| 2024-12-31 | 80.10M | +19.0% | 2026-03-16, Balance as of period end |
| 2023-12-31 | 67.31M | +1.6% | 2025-03-06, Balance as of period end |
| 2022-12-31 | 66.23M | +1.3% | 2024-03-11, Balance as of period end |
| 2021-12-31 | 65.39M | +35.5% | 2023-03-27, Balance as of period end |
| 2020-12-31 | 48.25M | +6.0% | 2023-03-27, Balance as of period end |
| 2019-12-31 | 45.52M | +1.0% | 2021-02-24, Balance as of period end |
| 2018-12-31 | 45.08M | +17.2% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 38.48M | +5.4% | 2019-02-27, Balance as of period end |
| 2016-12-31 | 36.49M | +1.3% | 2018-03-07, Balance as of period end |
| 2015-12-31 | 36.03M | n/m | 2016-03-07, Balance as of period end |
| 2014-12-31 | 996.5K | n/a | 2016-03-07, Balance as of period end |